MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2026 International Congress

    Efficacy of Vitamin C for Restless Legs Syndrome: A Systematic Review and Meta‑analysis of Randomized Controlled Trials

    A. Fornari Caprara, J. Pitton Rissardo, J. Patino, A. Mcgarry, I. Walker (Camden, USA)

    Objective: To evaluate the efficacy and safety of vitamin C (VITC) for treating restless legs syndrome (RLS) using evidence exclusively from randomized controlled trials (RCTs).…
  • 2026 International Congress

    Evaluation of Swallowing and Cough Function in older Patients with Parkinson’s Disease

    M. Nakamori, M. Toko, H. Yamada, R. Matsuyama, Y. Hayashi, M. Yoshikawa, T. Nagasaki, H. Maruyama (Hiroshima, Japan)

    Objective: This study aimed to characterize swallowing and cough function in older patients with Parkinson’s disease (PD) using a multidimensional assessment. Background: With population aging,…
  • 2026 International Congress

    Chronic Vanadium Exposure Promotes Memory Impairment and Aggregation of Alpha-Synuclein, Tau and Amyloid Beta in Mouse Brain

    O. Folarin, F. Olopade, T. Gilbert, A. Ladagu, P. Inês, O. Mustapha, L. Zethan, J. Olopade, T. Outeiro (Ibadan, Nigeria)

    Objective: In this study, we hypothesized that prolonged vanadium exposure may be a potential risk factor for Alzheimer's and Parkinson's diseases. Background: The interaction between…
  • 2026 International Congress

    The GLP-1 Agonist Paradox in Parkinson’s Disease: A Comparative Analysis of Lixisenatide and Exenatide Phase III Trial Outcomes and Neuroprotective Mechanisms

    F. Al-Zaidi (Almaty, Kazakhstan)

    Objective: To assess the pharmacological and methodological factors underlying the "GLP-1 paradox" by comparing the outcomes of lixisenatide and exenatide, with an emphasis on kinetics,…
  • 2026 International Congress

    Cognitive Progression in Elderly Essential Tremor Patients: Evidence from an 18-Month Prospective Cohort

    E. Abed (Cairo, Egypt)

    Objective: Essential tremor (ET) is one of the most prevalent neurological disorders and has increasingly been linked to cognitive dysfunction. However, most existing data regarding…
  • 2026 International Congress

    Lipid Alterations in Central Nervous System and Plasma During Early Stages of Parkinson’s Disease

    P. Thakur, U. Agarwal (Thiruvananthapuram, India)

    Objective: To identify early lipid alterations in a progressive mouse model of Parkinson’s disease (PD) and to determine whether peripheral lipid signatures reflect lipid changes…
  • 2026 International Congress

    Rare Neurotoxicity of Cotrimoxazole A Movement Disorder Presentation In Elderly Patient

    M. Keita Sr, A. Ouedraogo, E E. Fanorena, C. Bekara, M. Abdallah (Bourges, France)

    Objective: We report the case of an elderly woman with hyperkinetic movement disorders Background: Trimethoprim-sulfamethoxazole (TMP-SMX) is widely used for Pneumocystis jirovecii prophylaxis, but significant neurological toxicity…
  • 2026 International Congress

    Clinical Characteristics and Functional Impact of Tremor in Patients with Multiple Sclerosis in Nepal: A Cross-Sectional Observational Study

    AYU. Chandra, AVI. Chandra (Kathmandu, Nepal)

    Objective: To describe the clinical characteristics of tremor in multiple sclerosis (MS) patients in Nepal and assess its functional impact on daily living. To describe…
  • 2026 International Congress

    Antidepressants in Huntington’s Disease: A Meta Analysis of Mood and Motor Outcomes with Placebo-controlled Trials

    J. Patino, J. Pitton Rissardo, A. Fornari Caprara, A. Mcgarry, I. Walker, N. Rocha, A. Duker, E. Furr Stimming (Cincinnati, USA)

    Objective: To evaluate the efficacy of antidepressants for depression in Huntington’s disease (HD). Background: Depression is highly prevalent in HD. Despite frequent clinical use of…
  • 2026 International Congress

    Dynamics of Motor Fluctuations and Medication Challenges in Parkinson’s Disease

    O. Udomsirithamrong, R. Bhidayasiri, P. Panyakeaw (Bangkok, Thailand)

    Objective: To investigate the dynamics of tremor, bradykinesia, and finger dexterity during the OFF-to-ON transition using objective measures. Additionally, assesses medication administration challenges through a…
  • « Previous Page
  • 1
  • …
  • 17
  • 18
  • 19
  • 20
  • 21
  • …
  • 1942
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley